Euroapi (EAPI) Hisse Özeti
Euroapi S.A., beşeri ve veteriner ilaçların formülasyonunda kullanılan aktif farmasötik bileşenler ve ara ürünler geliştirmekte, üretmekte, pazarlamakta ve dağıtmaktadır. Daha fazla detay
| Kar Tanesi Skoru | |
|---|---|
| Değerleme | 4/6 |
| Gelecekteki Büyüme | 3/6 |
| Geçmiş Performans | 0/6 |
| Finansal Sağlık | 5/6 |
| Temettüler | 0/6 |
Ödüller
Risk Analizi
Risk kontrollerimizden EAPI için herhangi bir risk tespit edilmedi.
EAPI Community Fair Values
Create NarrativeSee what 11 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Euroapi S.A. Rakipler
Fiyat Geçmişi ve Performans
| Tarihsel hisse senedi fiyatları | |
|---|---|
| Güncel Hisse Fiyatı | €1.25 |
| 52 Haftanın En Yüksek Seviyesi | €3.44 |
| 52 Haftanın En Düşük Seviyesi | €1.22 |
| Beta | 0.98 |
| 1 Aylık Değişim | -1.42% |
| 3 Aylık Değişim | -4.13% |
| 1 Yıllık Değişim | -61.83% |
| 3 Yıllık Değişim | -87.98% |
| 5 Yıllık Değişim | n/a |
| Halka arzdan bu yana değişim | -90.74% |
Son Haberler & Güncellemeler
Anlatı Güncellemesi • Jun 30
EAPI: Reset Expectations And Higher Future P/E Could Support Rebound
Analysts have reduced their fair value estimate for Euroapi, cutting the price target from €2.00 to about €1.48. This is broadly in line with a recent move by the Street to bring targets down toward €1.70 as they factor in weaker revenue growth expectations and revised profitability assumptions alongside a higher future P/E multiple.
Anlatı Güncellemesi • Jun 16
EAPI: Revenue Contraction And Margin Pressure Will Continue To Restrain Future Earnings
Euroapi's analyst price target has been cut by €1.20 to €1.70, as analysts point to updated expectations for revenue contraction, profit margins, and a lower future P/E multiple. Analyst Commentary on Euroapi The latest research on Euroapi highlights a more cautious stance, with a reduced price target and a Neutral rating that suggests limited conviction in a strong near term recovery.Anlatı Güncellemesi • Jun 02
EAPI: Weaker Demand And Margin Pressure Will Drag On Future Earnings
Analysts have cut Euroapi's price target sharply, with recent revisions moving from €2.90 to a range of €1.70 and €1. This reflects more cautious assumptions on revenue trends, margins and a higher P/E multiple applied to the stock.Anlatı Güncellemesi • May 10
EAPI: Lower Expectations On 2026 Outlook Will Support Future Rebound Potential
Euroapi's analyst price target has shifted lower from about €3.08 to €2.00, with analysts pointing to Deutsche Bank's recent cut in its target to €1, along with updated views on revenue growth, profit margin, discount rate and future P/E assumptions. Analyst Commentary Bullish Takeaways Bullish analysts may see the lower price target range, now clustering around €1 to €2, as setting a more conservative bar for execution, which can reduce the risk of further valuation resets if expectations are now better aligned with current fundamentals.Recent updates
Anlatı Güncellemesi • Jun 30
EAPI: Reset Expectations And Higher Future P/E Could Support Rebound
Analysts have reduced their fair value estimate for Euroapi, cutting the price target from €2.00 to about €1.48. This is broadly in line with a recent move by the Street to bring targets down toward €1.70 as they factor in weaker revenue growth expectations and revised profitability assumptions alongside a higher future P/E multiple.Anlatı Güncellemesi • Jun 16
EAPI: Revenue Contraction And Margin Pressure Will Continue To Restrain Future Earnings
Euroapi's analyst price target has been cut by €1.20 to €1.70, as analysts point to updated expectations for revenue contraction, profit margins, and a lower future P/E multiple. Analyst Commentary on Euroapi The latest research on Euroapi highlights a more cautious stance, with a reduced price target and a Neutral rating that suggests limited conviction in a strong near term recovery.Anlatı Güncellemesi • Jun 02
EAPI: Weaker Demand And Margin Pressure Will Drag On Future Earnings
Analysts have cut Euroapi's price target sharply, with recent revisions moving from €2.90 to a range of €1.70 and €1. This reflects more cautious assumptions on revenue trends, margins and a higher P/E multiple applied to the stock.Anlatı Güncellemesi • May 10
EAPI: Lower Expectations On 2026 Outlook Will Support Future Rebound Potential
Euroapi's analyst price target has shifted lower from about €3.08 to €2.00, with analysts pointing to Deutsche Bank's recent cut in its target to €1, along with updated views on revenue growth, profit margin, discount rate and future P/E assumptions. Analyst Commentary Bullish Takeaways Bullish analysts may see the lower price target range, now clustering around €1 to €2, as setting a more conservative bar for execution, which can reduce the risk of further valuation resets if expectations are now better aligned with current fundamentals.Anlatı Güncellemesi • Apr 22
EAPI: Lower Demand And Portfolio Cuts Will Weigh On Future Earnings
Analysts have cut their price target on Euroapi to €1 from €2, with the change framed around more cautious assumptions despite essentially unchanged fair value, discount rate, revenue growth, profit margin and future P/E inputs in the latest update. Analyst Commentary Bearish analysts cutting the price target on Euroapi to €1 from €2 are signaling a more cautious stance around the stock, even though their core valuation inputs such as fair value frameworks, discount rate, revenue growth, profit margin and future P/E assumptions are described as essentially unchanged.
Anlatı Güncellemesi • Apr 08
EAPI: Future Cost Controls May Unlock Upside Despite 2026 Sales Headwinds
Analysts now see Euroapi's fair value closer to €2.90, down from €3.50, aligning with a series of lower Street price targets that most recently moved from €2.50 to €2 and then to €1. Analyst Commentary The recent cuts in fair value and Street targets to around €1 to €2 signal a cautious stance from research desks, with the most recent change bringing the target to €1 and maintaining a Sell view.Anlatı Güncellemesi • Mar 25
EAPI: Weaker 2026 Outlook And Portfolio Cuts Will Pressure Earnings Quality
Analysts have cut their price target on Euroapi to €1 from €2, with the shift broadly tied to ongoing caution reflected in recent research commentary that maintains a Sell stance and modest adjustments to revenue growth and profit margin assumptions. Analyst Commentary Recent research updates highlight a series of price target cuts on Euroapi, with bearish analysts reducing their fair value estimates while maintaining a cautious stance on the shares.Anlatı Güncellemesi • Mar 10
EAPI: Weaker 2025 Guidance Will Pressure Margins And Future Earnings Quality
Analysts have cut their Euroapi price target from €2 to €1, reflecting updated assumptions that now factor in lower revenue growth expectations, much slimmer profit margins, and a significantly higher future P/E multiple. Analyst Commentary Recent price target revisions point to a cautious stance from bearish analysts, who appear focused on execution risks and the implications for Euroapi's valuation.Anlatı Güncellemesi • Feb 24
EAPI: Lower 2025 Guidance And Reduced Multiple Will Shape Return Profile
Analysts have trimmed their price target on Euroapi to €2 from €2.50, citing updated assumptions on modest revenue growth, slightly higher profit margins, and a marginally lower future P/E multiple. Analyst Commentary Recent research points to a more cautious stance on Euroapi, with bearish analysts trimming their price targets to €2.Anlatı Güncellemesi • Feb 09
EAPI: Lower 2025 Outlook And Cautious Stance Will Shape Return Profile
Analysts have lowered their price target on Euroapi from €2.50 to €2, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E that collectively suggest a more cautious valuation stance. Analyst Commentary Bearish analysts have recently cut their price target on Euroapi from €2.50 to €2.Anlatı Güncellemesi • Jan 25
EAPI: Execution Risks And Lower Outlook Will Shape Future Return Profile
Narrative update Analysts have trimmed their price target on Euroapi by €0.50 to €2.00, citing updated assumptions on revenue growth, profit margins and forward P/E that keep their stance cautious on the shares. Analyst Commentary Recent research has reinforced a cautious stance on Euroapi, with bearish analysts trimming their price targets to €2.00.Anlatı Güncellemesi • Jan 10
EAPI: Lower Profitability Assumptions And New Partnership Will Shape Future Returns
Analysts have trimmed their price target on Euroapi to €2 from €2.50, citing softer assumptions around revenue growth, profit margins and a higher future P/E multiple as the key drivers of the reset. Analyst Commentary Bearish analysts are signalling a cautious stance on Euroapi by aligning around a lower price target of €2, narrowed from €2.50.Anlatı Güncellemesi • Dec 19
EAPI: Higher Discount Rate Will Outweigh Benefits From New Corticosteroid Partnership
Analysts have slightly reduced their Euroapi price target, reflecting a modest reassessment of fair value. This adjustment accounts for a higher discount rate, even as long term profit margin assumptions edge up and revenue declines appear marginally less severe.Analiz Makalesi • Dec 18
Calculating The Intrinsic Value Of Euroapi S.A. (EPA:EAPI)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Euroapi fair value estimate is €2.68 Euroapi's €2.40 share...Analiz Makalesi • Dec 18
Euroapi S.A. (EPA:EAPI) Not Doing Enough For Some Investors As Its Shares Slump 26%
Euroapi S.A. ( EPA:EAPI ) shareholders that were waiting for something to happen have been dealt a blow with a 26...Analiz Makalesi • Oct 03
Euroapi (EPA:EAPI) Has Debt But No Earnings; Should You Worry?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Analiz Makalesi • Aug 02
Euroapi S.A. (EPA:EAPI) Just Released Its Interim Results And Analysts Are Updating Their Estimates
It's been a mediocre week for Euroapi S.A. ( EPA:EAPI ) shareholders, with the stock dropping 12% to €2.79 in the week...
Yeni Anlatı • Mar 31
Capacity Expansion And Efficiency Improvements Will Shape Future Success
Euroapi focuses on high-margin differentiated APIs and CDMO services to boost sustainable revenue and profit margins through strategic project expansions.Analiz Makalesi • Mar 06
Analyst Estimates: Here's What Brokers Think Of Euroapi S.A. (EPA:EAPI) After Its Annual Report
It's been a good week for Euroapi S.A. ( EPA:EAPI ) shareholders, because the company has just released its latest...Analiz Makalesi • Oct 04
Euroapi S.A.'s (EPA:EAPI) Intrinsic Value Is Potentially 25% Below Its Share Price
Key Insights The projected fair value for Euroapi is €2.62 based on 2 Stage Free Cash Flow to Equity Current share...Analiz Makalesi • Jul 29
There's No Escaping Euroapi S.A.'s (EPA:EAPI) Muted Revenues Despite A 32% Share Price Rise
Euroapi S.A. ( EPA:EAPI ) shares have had a really impressive month, gaining 32% after a shaky period beforehand...Analiz Makalesi • May 24
Euroapi S.A. (EPA:EAPI) Stock Catapults 29% Though Its Price And Business Still Lag The Industry
Those holding Euroapi S.A. ( EPA:EAPI ) shares would be relieved that the share price has rebounded 29% in the last...Analiz Makalesi • Apr 10
Euroapi (EPA:EAPI) Seems To Be Using A Lot Of Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analiz Makalesi • Mar 03
Little Excitement Around Euroapi S.A.'s (EPA:EAPI) Revenues As Shares Take 31% Pounding
The Euroapi S.A. ( EPA:EAPI ) share price has fared very poorly over the last month, falling by a substantial 31%. For...Analiz Makalesi • Mar 02
Euroapi S.A. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
There's been a major selloff in Euroapi S.A. ( EPA:EAPI ) shares in the week since it released its yearly report, with...Analiz Makalesi • Dec 21
A Look At The Fair Value Of Euroapi S.A. (EPA:EAPI)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Euroapi fair value estimate is €5.03 With €5.47 share price...Analiz Makalesi • Aug 04
Analysts Are Updating Their Euroapi S.A. (EPA:EAPI) Estimates After Its Half-Yearly Results
It's been a good week for Euroapi S.A. ( EPA:EAPI ) shareholders, because the company has just released its latest...Analiz Makalesi • Aug 02
Is Euroapi S.A. (EPA:EAPI) Trading At A 49% Discount?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Euroapi fair value estimate is €24.50 Euroapi is estimated to...Analiz Makalesi • Jun 16
Euroapi S.A.'s (EPA:EAPI) Subdued P/S Might Signal An Opportunity
When close to half the companies operating in the Pharmaceuticals industry in France have price-to-sales ratios (or...Hissedar Getirileri
| EAPI | FR Pharmaceuticals | FR Pazar | |
|---|---|---|---|
| 7D | -5.9% | 2.5% | -0.7% |
| 1Y | -61.8% | -3.9% | 0.7% |
Getiri vs. Endüstri: EAPI geçen yıl % -3.9 oranında getiri sağlayan French Pharmaceuticals sektörünün gerisinde kaldı.
Getiri vs Piyasa: EAPI geçen yıl % 0.7 oranında getiri sağlayan French Piyasasının altında performans gösterdi.
Fiyat Oynaklığı
| EAPI volatility | |
|---|---|
| EAPI Average Weekly Movement | 5.2% |
| Pharmaceuticals Industry Average Movement | 4.2% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in FR Market | 10.9% |
| 10% least volatile stocks in FR Market | 2.5% |
İstikrarlı Hisse Senedi Fiyatı: EAPI son 3 ayda French piyasasına kıyasla önemli bir fiyat oynaklığı yaşamadı.
Zaman İçindeki Volatilite: EAPI 'nin haftalık oynaklığı ( 5% ) son bir yıldır istikrarlı seyretti.
Şirket Hakkında
| Kuruldu | Çalışanlar | CEO | Web sitesi |
|---|---|---|---|
| 2020 | 2,961 | David Seignolle | www.euroapi.com/en |
Euroapi S.A., beşeri ve veteriner ilaçların formülasyonunda kullanılan aktif farmasötik bileşenler ve ara ürünler geliştirmekte, üretmekte, pazarlamakta ve dağıtmaktadır. Şirket, katı faz kimyası; partikül mühendisliği; mikrobiyal fermantasyon; küçük molekül sentezi; prostaglandinler; steroidler ve hormonlar; opiatlar ve kontrollü maddeler ve lipidler kullanan farklı gelgit sınıfları için fason geliştirme üretim organizasyonu sağlamaktadır. Ürünlerini ilaç, jenerik ilaç üreticileri, hayvan sağlığı ürünleri üreticileri, tüketici sağlığı, beslenme ve kozmetik ürün şirketleri, biyoteknoloji şirketleri ve dağıtım şirketlerinin yanı sıra sözleşmeli geliştirme ve üretim organizasyonuna sunmaktadır.
Euroapi S.A. Temel Bilgiler Özeti
| EAPI temel i̇stati̇sti̇kler | |
|---|---|
| Piyasa değeri | €119.37m |
| Kazançlar(TTM) | -€211.20m |
| Gelir(TTM) | €852.60m |
0.1x
P/S Oranı-0.6x
F/K OranıEAPI aşırı değerli mi?
Gerçeğe Uygun Değer ve değerleme analizine bakınızKazanç ve Gelir
| EAPI gelir tablosu (TTM) | |
|---|---|
| Gelir | €852.60m |
| Gelir Maliyeti | €707.70m |
| Brüt Kâr | €144.90m |
| Diğer Giderler | €356.10m |
| Kazançlar | -€211.20m |
Son Raporlanan Kazançlar
Dec 31, 2025
Sonraki Kazanç Tarihi
Jul 29, 2026
| Hisse başına kazanç (EPS) | -2.22 |
| Brüt Marj | 17.00% |
| Net Kâr Marjı | -24.77% |
| Borç/Özkaynak Oranı | 5.8% |
EAPI uzun vadede nasıl bir performans gösterdi?
Geçmiş performansı ve karşılaştırmayı görünŞirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/07/09 20:29 |
| Gün Sonu Hisse Fiyatı | 2026/07/09 00:00 |
| Kazançlar | 2025/12/31 |
| Yıllık Kazançlar | 2025/12/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları GitHub sayfamızda mevcuttur; ayrıca raporlarımızı nasıl kullanacağınıza dair kılavuzlarımız ve YouTube'da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
Euroapi S.A. 11 Bu analistlerden 4, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Justin Steven Smith | Bernstein |
| Patrick Andrew Wood | BofA Global Research |
| Fynn Scherzler | Deutsche Bank |